NCT02849977 |
|
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
|
View
|
NCT03479437 |
|
The TEMPO Tracing the Effect of the MC4 Pathway in Obesity Registry
|
View
|
NCT02507492 |
|
RM-493 Treatment Trial in Proopiomelanocortin POMC Deficient Patients
|
View
|
NCT03621007 |
|
An ObservationalProspective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC PCSK1 or LEPR Genes
|
View
|
NCT04966741 |
|
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity
|
View
|
NCT05093634 |
|
EMANATE A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
|
View
|
NCT05532020 |
|
An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities
|
View
|
NCT02896192 |
|
Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin POMC Deficiency Obesity
|
View
|
NCT06041841 |
|
A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity
|
View
|
NCT06239064 |
|
Early Genetic Identification of Obesity
|
View
|